Pharmacoeconomic evaluation of original and generic temozolomide capsules in the treatment of glioma
-
Published:2023-06
Issue:1
Volume:1
Page:26-31
-
ISSN:2949-866X
-
Container-title:Intelligent Pharmacy
-
language:en
-
Short-container-title:Intelligent Pharmacy
Author:
Gu Ming,
Diao Changdong,
Sullivan Mitchell A.ORCID,
Zhu Haixia,
Yuan Qi,
Liu Jinmei,
Li Shijun,
Zhang Yu,
Deng Bin,
Shi Chen
Reference11 articles.
1. Current epidemiological trends and surveillance issues in brain tumors;Davis;Expert Rev Anticancer Ther,2001
2. Glioma subclassifications and their clinical significance;Chen;Neurotherapeutics,2017
3. Antitumor imidazotetrazines. 1.Synthesis and chemistry of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5- tetrazin-4(3 H)-one, a novel broad-spectrum antitumor agent;Stevens;J Med Chem,1984
4. From triazines and triazenes to temozolomide;Stevens;Eur J Cancer,1993
5. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005